Pharmacists’ Look at the Future of GLP-1 CompoundingByBrian Nowosielski,Hailey Choi, PharmD, BCACP, CDCES,Jana Murry, PharmD, RPh,Spencer Casella, PharmD, RPhAugust 20th 2026
FDA Approves Autoinjector of Lerodalcibep-Liga With Updated IndicationByAshley Gallagher, MAAugust 17th 2026
FDA Approves Orzeyful, First Drug Targeting Underlying Cause of NarcolepsyByAshley Gallagher, MAAugust 6th 2026